Medical Care
Global Early Detection of Multiple Cancers Market Research Report 2025
- May 05, 25
- ID: 228369
- Pages: 90
- Figures: 82
- Views: 7
The global market for Early Detection of Multiple Cancers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Early Detection of Multiple Cancers is a diagnosis and treatment method specifically for early-stage cancer patients, with the purpose of early detection and early treatment, so as to reduce the pain, mental and economic burden of patients. Strive for early recovery of cancer patients through early diagnosis and treatment of cancer.
North American market for Early Detection of Multiple Cancers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Early Detection of Multiple Cancers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Early Detection of Multiple Cancers in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Early Detection of Multiple Cancers include Grail, Exact Sciences, Foundation Medicine, AnchorDx, Guardant Health, Burning Rock Biotech, GENECAST, Labporatory for Advanced Medicine and Health Group, Singlera Genomics, Johns Hopkins Medicine, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Early Detection of Multiple Cancers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Early Detection of Multiple Cancers.
The Early Detection of Multiple Cancers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Early Detection of Multiple Cancers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Early Detection of Multiple Cancers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grail
Exact Sciences
Foundation Medicine
AnchorDx
Guardant Health
Burning Rock Biotech
GENECAST
Labporatory for Advanced Medicine and Health Group
Singlera Genomics
Johns Hopkins Medicine
Bioscience
Genetron Holdings
Shenzhen Ruisi
Shanghai Majorbio Bio-Pharm Technology
Shanghai Gurong
Segment by Type
Liquid Biopsy
Gene Panel
Others
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Early Detection of Multiple Cancers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Early Detection of Multiple Cancers is a diagnosis and treatment method specifically for early-stage cancer patients, with the purpose of early detection and early treatment, so as to reduce the pain, mental and economic burden of patients. Strive for early recovery of cancer patients through early diagnosis and treatment of cancer.
North American market for Early Detection of Multiple Cancers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Early Detection of Multiple Cancers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Early Detection of Multiple Cancers in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Early Detection of Multiple Cancers include Grail, Exact Sciences, Foundation Medicine, AnchorDx, Guardant Health, Burning Rock Biotech, GENECAST, Labporatory for Advanced Medicine and Health Group, Singlera Genomics, Johns Hopkins Medicine, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Early Detection of Multiple Cancers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Early Detection of Multiple Cancers.
The Early Detection of Multiple Cancers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Early Detection of Multiple Cancers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Early Detection of Multiple Cancers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grail
Exact Sciences
Foundation Medicine
AnchorDx
Guardant Health
Burning Rock Biotech
GENECAST
Labporatory for Advanced Medicine and Health Group
Singlera Genomics
Johns Hopkins Medicine
Bioscience
Genetron Holdings
Shenzhen Ruisi
Shanghai Majorbio Bio-Pharm Technology
Shanghai Gurong
Segment by Type
Liquid Biopsy
Gene Panel
Others
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Early Detection of Multiple Cancers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Early Detection of Multiple Cancers Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liquid Biopsy
1.2.3 Gene Panel
1.2.4 Others
1.3 Market by Application
1.3.1 Global Early Detection of Multiple Cancers Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Early Detection of Multiple Cancers Market Perspective (2020-2031)
2.2 Global Early Detection of Multiple Cancers Growth Trends by Region
2.2.1 Global Early Detection of Multiple Cancers Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Early Detection of Multiple Cancers Historic Market Size by Region (2020-2025)
2.2.3 Early Detection of Multiple Cancers Forecasted Market Size by Region (2026-2031)
2.3 Early Detection of Multiple Cancers Market Dynamics
2.3.1 Early Detection of Multiple Cancers Industry Trends
2.3.2 Early Detection of Multiple Cancers Market Drivers
2.3.3 Early Detection of Multiple Cancers Market Challenges
2.3.4 Early Detection of Multiple Cancers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Early Detection of Multiple Cancers Players by Revenue
3.1.1 Global Top Early Detection of Multiple Cancers Players by Revenue (2020-2025)
3.1.2 Global Early Detection of Multiple Cancers Revenue Market Share by Players (2020-2025)
3.2 Global Early Detection of Multiple Cancers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Early Detection of Multiple Cancers Revenue
3.4 Global Early Detection of Multiple Cancers Market Concentration Ratio
3.4.1 Global Early Detection of Multiple Cancers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Early Detection of Multiple Cancers Revenue in 2024
3.5 Global Key Players of Early Detection of Multiple Cancers Head office and Area Served
3.6 Global Key Players of Early Detection of Multiple Cancers, Product and Application
3.7 Global Key Players of Early Detection of Multiple Cancers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Early Detection of Multiple Cancers Breakdown Data by Type
4.1 Global Early Detection of Multiple Cancers Historic Market Size by Type (2020-2025)
4.2 Global Early Detection of Multiple Cancers Forecasted Market Size by Type (2026-2031)
5 Early Detection of Multiple Cancers Breakdown Data by Application
5.1 Global Early Detection of Multiple Cancers Historic Market Size by Application (2020-2025)
5.2 Global Early Detection of Multiple Cancers Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Early Detection of Multiple Cancers Market Size (2020-2031)
6.2 North America Early Detection of Multiple Cancers Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Early Detection of Multiple Cancers Market Size by Country (2020-2025)
6.4 North America Early Detection of Multiple Cancers Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Early Detection of Multiple Cancers Market Size (2020-2031)
7.2 Europe Early Detection of Multiple Cancers Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Early Detection of Multiple Cancers Market Size by Country (2020-2025)
7.4 Europe Early Detection of Multiple Cancers Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Early Detection of Multiple Cancers Market Size (2020-2031)
8.2 Asia-Pacific Early Detection of Multiple Cancers Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Early Detection of Multiple Cancers Market Size by Region (2020-2025)
8.4 Asia-Pacific Early Detection of Multiple Cancers Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Early Detection of Multiple Cancers Market Size (2020-2031)
9.2 Latin America Early Detection of Multiple Cancers Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Early Detection of Multiple Cancers Market Size by Country (2020-2025)
9.4 Latin America Early Detection of Multiple Cancers Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Early Detection of Multiple Cancers Market Size (2020-2031)
10.2 Middle East & Africa Early Detection of Multiple Cancers Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Early Detection of Multiple Cancers Market Size by Country (2020-2025)
10.4 Middle East & Africa Early Detection of Multiple Cancers Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grail
11.1.1 Grail Company Details
11.1.2 Grail Business Overview
11.1.3 Grail Early Detection of Multiple Cancers Introduction
11.1.4 Grail Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.1.5 Grail Recent Development
11.2 Exact Sciences
11.2.1 Exact Sciences Company Details
11.2.2 Exact Sciences Business Overview
11.2.3 Exact Sciences Early Detection of Multiple Cancers Introduction
11.2.4 Exact Sciences Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.2.5 Exact Sciences Recent Development
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Details
11.3.2 Foundation Medicine Business Overview
11.3.3 Foundation Medicine Early Detection of Multiple Cancers Introduction
11.3.4 Foundation Medicine Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.3.5 Foundation Medicine Recent Development
11.4 AnchorDx
11.4.1 AnchorDx Company Details
11.4.2 AnchorDx Business Overview
11.4.3 AnchorDx Early Detection of Multiple Cancers Introduction
11.4.4 AnchorDx Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.4.5 AnchorDx Recent Development
11.5 Guardant Health
11.5.1 Guardant Health Company Details
11.5.2 Guardant Health Business Overview
11.5.3 Guardant Health Early Detection of Multiple Cancers Introduction
11.5.4 Guardant Health Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.5.5 Guardant Health Recent Development
11.6 Burning Rock Biotech
11.6.1 Burning Rock Biotech Company Details
11.6.2 Burning Rock Biotech Business Overview
11.6.3 Burning Rock Biotech Early Detection of Multiple Cancers Introduction
11.6.4 Burning Rock Biotech Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.6.5 Burning Rock Biotech Recent Development
11.7 GENECAST
11.7.1 GENECAST Company Details
11.7.2 GENECAST Business Overview
11.7.3 GENECAST Early Detection of Multiple Cancers Introduction
11.7.4 GENECAST Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.7.5 GENECAST Recent Development
11.8 Labporatory for Advanced Medicine and Health Group
11.8.1 Labporatory for Advanced Medicine and Health Group Company Details
11.8.2 Labporatory for Advanced Medicine and Health Group Business Overview
11.8.3 Labporatory for Advanced Medicine and Health Group Early Detection of Multiple Cancers Introduction
11.8.4 Labporatory for Advanced Medicine and Health Group Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.8.5 Labporatory for Advanced Medicine and Health Group Recent Development
11.9 Singlera Genomics
11.9.1 Singlera Genomics Company Details
11.9.2 Singlera Genomics Business Overview
11.9.3 Singlera Genomics Early Detection of Multiple Cancers Introduction
11.9.4 Singlera Genomics Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.9.5 Singlera Genomics Recent Development
11.10 Johns Hopkins Medicine
11.10.1 Johns Hopkins Medicine Company Details
11.10.2 Johns Hopkins Medicine Business Overview
11.10.3 Johns Hopkins Medicine Early Detection of Multiple Cancers Introduction
11.10.4 Johns Hopkins Medicine Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.10.5 Johns Hopkins Medicine Recent Development
11.11 Bioscience
11.11.1 Bioscience Company Details
11.11.2 Bioscience Business Overview
11.11.3 Bioscience Early Detection of Multiple Cancers Introduction
11.11.4 Bioscience Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.11.5 Bioscience Recent Development
11.12 Genetron Holdings
11.12.1 Genetron Holdings Company Details
11.12.2 Genetron Holdings Business Overview
11.12.3 Genetron Holdings Early Detection of Multiple Cancers Introduction
11.12.4 Genetron Holdings Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.12.5 Genetron Holdings Recent Development
11.13 Shenzhen Ruisi
11.13.1 Shenzhen Ruisi Company Details
11.13.2 Shenzhen Ruisi Business Overview
11.13.3 Shenzhen Ruisi Early Detection of Multiple Cancers Introduction
11.13.4 Shenzhen Ruisi Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.13.5 Shenzhen Ruisi Recent Development
11.14 Shanghai Majorbio Bio-Pharm Technology
11.14.1 Shanghai Majorbio Bio-Pharm Technology Company Details
11.14.2 Shanghai Majorbio Bio-Pharm Technology Business Overview
11.14.3 Shanghai Majorbio Bio-Pharm Technology Early Detection of Multiple Cancers Introduction
11.14.4 Shanghai Majorbio Bio-Pharm Technology Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.14.5 Shanghai Majorbio Bio-Pharm Technology Recent Development
11.15 Shanghai Gurong
11.15.1 Shanghai Gurong Company Details
11.15.2 Shanghai Gurong Business Overview
11.15.3 Shanghai Gurong Early Detection of Multiple Cancers Introduction
11.15.4 Shanghai Gurong Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.15.5 Shanghai Gurong Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Early Detection of Multiple Cancers Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liquid Biopsy
1.2.3 Gene Panel
1.2.4 Others
1.3 Market by Application
1.3.1 Global Early Detection of Multiple Cancers Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Early Detection of Multiple Cancers Market Perspective (2020-2031)
2.2 Global Early Detection of Multiple Cancers Growth Trends by Region
2.2.1 Global Early Detection of Multiple Cancers Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Early Detection of Multiple Cancers Historic Market Size by Region (2020-2025)
2.2.3 Early Detection of Multiple Cancers Forecasted Market Size by Region (2026-2031)
2.3 Early Detection of Multiple Cancers Market Dynamics
2.3.1 Early Detection of Multiple Cancers Industry Trends
2.3.2 Early Detection of Multiple Cancers Market Drivers
2.3.3 Early Detection of Multiple Cancers Market Challenges
2.3.4 Early Detection of Multiple Cancers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Early Detection of Multiple Cancers Players by Revenue
3.1.1 Global Top Early Detection of Multiple Cancers Players by Revenue (2020-2025)
3.1.2 Global Early Detection of Multiple Cancers Revenue Market Share by Players (2020-2025)
3.2 Global Early Detection of Multiple Cancers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Early Detection of Multiple Cancers Revenue
3.4 Global Early Detection of Multiple Cancers Market Concentration Ratio
3.4.1 Global Early Detection of Multiple Cancers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Early Detection of Multiple Cancers Revenue in 2024
3.5 Global Key Players of Early Detection of Multiple Cancers Head office and Area Served
3.6 Global Key Players of Early Detection of Multiple Cancers, Product and Application
3.7 Global Key Players of Early Detection of Multiple Cancers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Early Detection of Multiple Cancers Breakdown Data by Type
4.1 Global Early Detection of Multiple Cancers Historic Market Size by Type (2020-2025)
4.2 Global Early Detection of Multiple Cancers Forecasted Market Size by Type (2026-2031)
5 Early Detection of Multiple Cancers Breakdown Data by Application
5.1 Global Early Detection of Multiple Cancers Historic Market Size by Application (2020-2025)
5.2 Global Early Detection of Multiple Cancers Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Early Detection of Multiple Cancers Market Size (2020-2031)
6.2 North America Early Detection of Multiple Cancers Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Early Detection of Multiple Cancers Market Size by Country (2020-2025)
6.4 North America Early Detection of Multiple Cancers Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Early Detection of Multiple Cancers Market Size (2020-2031)
7.2 Europe Early Detection of Multiple Cancers Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Early Detection of Multiple Cancers Market Size by Country (2020-2025)
7.4 Europe Early Detection of Multiple Cancers Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Early Detection of Multiple Cancers Market Size (2020-2031)
8.2 Asia-Pacific Early Detection of Multiple Cancers Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Early Detection of Multiple Cancers Market Size by Region (2020-2025)
8.4 Asia-Pacific Early Detection of Multiple Cancers Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Early Detection of Multiple Cancers Market Size (2020-2031)
9.2 Latin America Early Detection of Multiple Cancers Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Early Detection of Multiple Cancers Market Size by Country (2020-2025)
9.4 Latin America Early Detection of Multiple Cancers Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Early Detection of Multiple Cancers Market Size (2020-2031)
10.2 Middle East & Africa Early Detection of Multiple Cancers Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Early Detection of Multiple Cancers Market Size by Country (2020-2025)
10.4 Middle East & Africa Early Detection of Multiple Cancers Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grail
11.1.1 Grail Company Details
11.1.2 Grail Business Overview
11.1.3 Grail Early Detection of Multiple Cancers Introduction
11.1.4 Grail Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.1.5 Grail Recent Development
11.2 Exact Sciences
11.2.1 Exact Sciences Company Details
11.2.2 Exact Sciences Business Overview
11.2.3 Exact Sciences Early Detection of Multiple Cancers Introduction
11.2.4 Exact Sciences Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.2.5 Exact Sciences Recent Development
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Details
11.3.2 Foundation Medicine Business Overview
11.3.3 Foundation Medicine Early Detection of Multiple Cancers Introduction
11.3.4 Foundation Medicine Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.3.5 Foundation Medicine Recent Development
11.4 AnchorDx
11.4.1 AnchorDx Company Details
11.4.2 AnchorDx Business Overview
11.4.3 AnchorDx Early Detection of Multiple Cancers Introduction
11.4.4 AnchorDx Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.4.5 AnchorDx Recent Development
11.5 Guardant Health
11.5.1 Guardant Health Company Details
11.5.2 Guardant Health Business Overview
11.5.3 Guardant Health Early Detection of Multiple Cancers Introduction
11.5.4 Guardant Health Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.5.5 Guardant Health Recent Development
11.6 Burning Rock Biotech
11.6.1 Burning Rock Biotech Company Details
11.6.2 Burning Rock Biotech Business Overview
11.6.3 Burning Rock Biotech Early Detection of Multiple Cancers Introduction
11.6.4 Burning Rock Biotech Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.6.5 Burning Rock Biotech Recent Development
11.7 GENECAST
11.7.1 GENECAST Company Details
11.7.2 GENECAST Business Overview
11.7.3 GENECAST Early Detection of Multiple Cancers Introduction
11.7.4 GENECAST Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.7.5 GENECAST Recent Development
11.8 Labporatory for Advanced Medicine and Health Group
11.8.1 Labporatory for Advanced Medicine and Health Group Company Details
11.8.2 Labporatory for Advanced Medicine and Health Group Business Overview
11.8.3 Labporatory for Advanced Medicine and Health Group Early Detection of Multiple Cancers Introduction
11.8.4 Labporatory for Advanced Medicine and Health Group Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.8.5 Labporatory for Advanced Medicine and Health Group Recent Development
11.9 Singlera Genomics
11.9.1 Singlera Genomics Company Details
11.9.2 Singlera Genomics Business Overview
11.9.3 Singlera Genomics Early Detection of Multiple Cancers Introduction
11.9.4 Singlera Genomics Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.9.5 Singlera Genomics Recent Development
11.10 Johns Hopkins Medicine
11.10.1 Johns Hopkins Medicine Company Details
11.10.2 Johns Hopkins Medicine Business Overview
11.10.3 Johns Hopkins Medicine Early Detection of Multiple Cancers Introduction
11.10.4 Johns Hopkins Medicine Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.10.5 Johns Hopkins Medicine Recent Development
11.11 Bioscience
11.11.1 Bioscience Company Details
11.11.2 Bioscience Business Overview
11.11.3 Bioscience Early Detection of Multiple Cancers Introduction
11.11.4 Bioscience Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.11.5 Bioscience Recent Development
11.12 Genetron Holdings
11.12.1 Genetron Holdings Company Details
11.12.2 Genetron Holdings Business Overview
11.12.3 Genetron Holdings Early Detection of Multiple Cancers Introduction
11.12.4 Genetron Holdings Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.12.5 Genetron Holdings Recent Development
11.13 Shenzhen Ruisi
11.13.1 Shenzhen Ruisi Company Details
11.13.2 Shenzhen Ruisi Business Overview
11.13.3 Shenzhen Ruisi Early Detection of Multiple Cancers Introduction
11.13.4 Shenzhen Ruisi Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.13.5 Shenzhen Ruisi Recent Development
11.14 Shanghai Majorbio Bio-Pharm Technology
11.14.1 Shanghai Majorbio Bio-Pharm Technology Company Details
11.14.2 Shanghai Majorbio Bio-Pharm Technology Business Overview
11.14.3 Shanghai Majorbio Bio-Pharm Technology Early Detection of Multiple Cancers Introduction
11.14.4 Shanghai Majorbio Bio-Pharm Technology Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.14.5 Shanghai Majorbio Bio-Pharm Technology Recent Development
11.15 Shanghai Gurong
11.15.1 Shanghai Gurong Company Details
11.15.2 Shanghai Gurong Business Overview
11.15.3 Shanghai Gurong Early Detection of Multiple Cancers Introduction
11.15.4 Shanghai Gurong Revenue in Early Detection of Multiple Cancers Business (2020-2025)
11.15.5 Shanghai Gurong Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Early Detection of Multiple Cancers Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Liquid Biopsy
Table 3. Key Players of Gene Panel
Table 4. Key Players of Others
Table 5. Global Early Detection of Multiple Cancers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Early Detection of Multiple Cancers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Early Detection of Multiple Cancers Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Early Detection of Multiple Cancers Market Share by Region (2020-2025)
Table 9. Global Early Detection of Multiple Cancers Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Early Detection of Multiple Cancers Market Share by Region (2026-2031)
Table 11. Early Detection of Multiple Cancers Market Trends
Table 12. Early Detection of Multiple Cancers Market Drivers
Table 13. Early Detection of Multiple Cancers Market Challenges
Table 14. Early Detection of Multiple Cancers Market Restraints
Table 15. Global Early Detection of Multiple Cancers Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Early Detection of Multiple Cancers Market Share by Players (2020-2025)
Table 17. Global Top Early Detection of Multiple Cancers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Early Detection of Multiple Cancers as of 2024)
Table 18. Ranking of Global Top Early Detection of Multiple Cancers Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Early Detection of Multiple Cancers Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Early Detection of Multiple Cancers, Headquarters and Area Served
Table 21. Global Key Players of Early Detection of Multiple Cancers, Product and Application
Table 22. Global Key Players of Early Detection of Multiple Cancers, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Early Detection of Multiple Cancers Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Early Detection of Multiple Cancers Revenue Market Share by Type (2020-2025)
Table 26. Global Early Detection of Multiple Cancers Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Early Detection of Multiple Cancers Revenue Market Share by Type (2026-2031)
Table 28. Global Early Detection of Multiple Cancers Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Early Detection of Multiple Cancers Revenue Market Share by Application (2020-2025)
Table 30. Global Early Detection of Multiple Cancers Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Early Detection of Multiple Cancers Revenue Market Share by Application (2026-2031)
Table 32. North America Early Detection of Multiple Cancers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Early Detection of Multiple Cancers Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Early Detection of Multiple Cancers Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Early Detection of Multiple Cancers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Early Detection of Multiple Cancers Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Early Detection of Multiple Cancers Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Early Detection of Multiple Cancers Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Early Detection of Multiple Cancers Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Early Detection of Multiple Cancers Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Early Detection of Multiple Cancers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Early Detection of Multiple Cancers Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Early Detection of Multiple Cancers Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Early Detection of Multiple Cancers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Early Detection of Multiple Cancers Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Early Detection of Multiple Cancers Market Size by Country (2026-2031) & (US$ Million)
Table 47. Grail Company Details
Table 48. Grail Business Overview
Table 49. Grail Early Detection of Multiple Cancers Product
Table 50. Grail Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 51. Grail Recent Development
Table 52. Exact Sciences Company Details
Table 53. Exact Sciences Business Overview
Table 54. Exact Sciences Early Detection of Multiple Cancers Product
Table 55. Exact Sciences Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 56. Exact Sciences Recent Development
Table 57. Foundation Medicine Company Details
Table 58. Foundation Medicine Business Overview
Table 59. Foundation Medicine Early Detection of Multiple Cancers Product
Table 60. Foundation Medicine Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 61. Foundation Medicine Recent Development
Table 62. AnchorDx Company Details
Table 63. AnchorDx Business Overview
Table 64. AnchorDx Early Detection of Multiple Cancers Product
Table 65. AnchorDx Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 66. AnchorDx Recent Development
Table 67. Guardant Health Company Details
Table 68. Guardant Health Business Overview
Table 69. Guardant Health Early Detection of Multiple Cancers Product
Table 70. Guardant Health Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 71. Guardant Health Recent Development
Table 72. Burning Rock Biotech Company Details
Table 73. Burning Rock Biotech Business Overview
Table 74. Burning Rock Biotech Early Detection of Multiple Cancers Product
Table 75. Burning Rock Biotech Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 76. Burning Rock Biotech Recent Development
Table 77. GENECAST Company Details
Table 78. GENECAST Business Overview
Table 79. GENECAST Early Detection of Multiple Cancers Product
Table 80. GENECAST Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 81. GENECAST Recent Development
Table 82. Labporatory for Advanced Medicine and Health Group Company Details
Table 83. Labporatory for Advanced Medicine and Health Group Business Overview
Table 84. Labporatory for Advanced Medicine and Health Group Early Detection of Multiple Cancers Product
Table 85. Labporatory for Advanced Medicine and Health Group Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 86. Labporatory for Advanced Medicine and Health Group Recent Development
Table 87. Singlera Genomics Company Details
Table 88. Singlera Genomics Business Overview
Table 89. Singlera Genomics Early Detection of Multiple Cancers Product
Table 90. Singlera Genomics Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 91. Singlera Genomics Recent Development
Table 92. Johns Hopkins Medicine Company Details
Table 93. Johns Hopkins Medicine Business Overview
Table 94. Johns Hopkins Medicine Early Detection of Multiple Cancers Product
Table 95. Johns Hopkins Medicine Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 96. Johns Hopkins Medicine Recent Development
Table 97. Bioscience Company Details
Table 98. Bioscience Business Overview
Table 99. Bioscience Early Detection of Multiple Cancers Product
Table 100. Bioscience Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 101. Bioscience Recent Development
Table 102. Genetron Holdings Company Details
Table 103. Genetron Holdings Business Overview
Table 104. Genetron Holdings Early Detection of Multiple Cancers Product
Table 105. Genetron Holdings Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 106. Genetron Holdings Recent Development
Table 107. Shenzhen Ruisi Company Details
Table 108. Shenzhen Ruisi Business Overview
Table 109. Shenzhen Ruisi Early Detection of Multiple Cancers Product
Table 110. Shenzhen Ruisi Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 111. Shenzhen Ruisi Recent Development
Table 112. Shanghai Majorbio Bio-Pharm Technology Company Details
Table 113. Shanghai Majorbio Bio-Pharm Technology Business Overview
Table 114. Shanghai Majorbio Bio-Pharm Technology Early Detection of Multiple Cancers Product
Table 115. Shanghai Majorbio Bio-Pharm Technology Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 116. Shanghai Majorbio Bio-Pharm Technology Recent Development
Table 117. Shanghai Gurong Company Details
Table 118. Shanghai Gurong Business Overview
Table 119. Shanghai Gurong Early Detection of Multiple Cancers Product
Table 120. Shanghai Gurong Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 121. Shanghai Gurong Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Early Detection of Multiple Cancers Picture
Figure 2. Global Early Detection of Multiple Cancers Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Early Detection of Multiple Cancers Market Share by Type: 2024 VS 2031
Figure 4. Liquid Biopsy Features
Figure 5. Gene Panel Features
Figure 6. Others Features
Figure 7. Global Early Detection of Multiple Cancers Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Early Detection of Multiple Cancers Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Diagnostic Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Early Detection of Multiple Cancers Report Years Considered
Figure 13. Global Early Detection of Multiple Cancers Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Early Detection of Multiple Cancers Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Early Detection of Multiple Cancers Market Share by Region: 2024 VS 2031
Figure 16. Global Early Detection of Multiple Cancers Market Share by Players in 2024
Figure 17. Global Top Early Detection of Multiple Cancers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Early Detection of Multiple Cancers as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Early Detection of Multiple Cancers Revenue in 2024
Figure 19. North America Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Early Detection of Multiple Cancers Market Share by Country (2020-2031)
Figure 21. United States Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Early Detection of Multiple Cancers Market Share by Country (2020-2031)
Figure 25. Germany Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Early Detection of Multiple Cancers Market Share by Region (2020-2031)
Figure 33. China Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Early Detection of Multiple Cancers Market Share by Country (2020-2031)
Figure 41. Mexico Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Early Detection of Multiple Cancers Market Share by Country (2020-2031)
Figure 45. Turkey Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Grail Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 49. Exact Sciences Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 50. Foundation Medicine Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 51. AnchorDx Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 52. Guardant Health Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 53. Burning Rock Biotech Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 54. GENECAST Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 55. Labporatory for Advanced Medicine and Health Group Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 56. Singlera Genomics Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 57. Johns Hopkins Medicine Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 58. Bioscience Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 59. Genetron Holdings Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 60. Shenzhen Ruisi Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 61. Shanghai Majorbio Bio-Pharm Technology Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 62. Shanghai Gurong Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Early Detection of Multiple Cancers Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Liquid Biopsy
Table 3. Key Players of Gene Panel
Table 4. Key Players of Others
Table 5. Global Early Detection of Multiple Cancers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Early Detection of Multiple Cancers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Early Detection of Multiple Cancers Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Early Detection of Multiple Cancers Market Share by Region (2020-2025)
Table 9. Global Early Detection of Multiple Cancers Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Early Detection of Multiple Cancers Market Share by Region (2026-2031)
Table 11. Early Detection of Multiple Cancers Market Trends
Table 12. Early Detection of Multiple Cancers Market Drivers
Table 13. Early Detection of Multiple Cancers Market Challenges
Table 14. Early Detection of Multiple Cancers Market Restraints
Table 15. Global Early Detection of Multiple Cancers Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Early Detection of Multiple Cancers Market Share by Players (2020-2025)
Table 17. Global Top Early Detection of Multiple Cancers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Early Detection of Multiple Cancers as of 2024)
Table 18. Ranking of Global Top Early Detection of Multiple Cancers Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Early Detection of Multiple Cancers Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Early Detection of Multiple Cancers, Headquarters and Area Served
Table 21. Global Key Players of Early Detection of Multiple Cancers, Product and Application
Table 22. Global Key Players of Early Detection of Multiple Cancers, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Early Detection of Multiple Cancers Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Early Detection of Multiple Cancers Revenue Market Share by Type (2020-2025)
Table 26. Global Early Detection of Multiple Cancers Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Early Detection of Multiple Cancers Revenue Market Share by Type (2026-2031)
Table 28. Global Early Detection of Multiple Cancers Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Early Detection of Multiple Cancers Revenue Market Share by Application (2020-2025)
Table 30. Global Early Detection of Multiple Cancers Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Early Detection of Multiple Cancers Revenue Market Share by Application (2026-2031)
Table 32. North America Early Detection of Multiple Cancers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Early Detection of Multiple Cancers Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Early Detection of Multiple Cancers Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Early Detection of Multiple Cancers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Early Detection of Multiple Cancers Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Early Detection of Multiple Cancers Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Early Detection of Multiple Cancers Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Early Detection of Multiple Cancers Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Early Detection of Multiple Cancers Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Early Detection of Multiple Cancers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Early Detection of Multiple Cancers Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Early Detection of Multiple Cancers Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Early Detection of Multiple Cancers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Early Detection of Multiple Cancers Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Early Detection of Multiple Cancers Market Size by Country (2026-2031) & (US$ Million)
Table 47. Grail Company Details
Table 48. Grail Business Overview
Table 49. Grail Early Detection of Multiple Cancers Product
Table 50. Grail Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 51. Grail Recent Development
Table 52. Exact Sciences Company Details
Table 53. Exact Sciences Business Overview
Table 54. Exact Sciences Early Detection of Multiple Cancers Product
Table 55. Exact Sciences Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 56. Exact Sciences Recent Development
Table 57. Foundation Medicine Company Details
Table 58. Foundation Medicine Business Overview
Table 59. Foundation Medicine Early Detection of Multiple Cancers Product
Table 60. Foundation Medicine Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 61. Foundation Medicine Recent Development
Table 62. AnchorDx Company Details
Table 63. AnchorDx Business Overview
Table 64. AnchorDx Early Detection of Multiple Cancers Product
Table 65. AnchorDx Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 66. AnchorDx Recent Development
Table 67. Guardant Health Company Details
Table 68. Guardant Health Business Overview
Table 69. Guardant Health Early Detection of Multiple Cancers Product
Table 70. Guardant Health Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 71. Guardant Health Recent Development
Table 72. Burning Rock Biotech Company Details
Table 73. Burning Rock Biotech Business Overview
Table 74. Burning Rock Biotech Early Detection of Multiple Cancers Product
Table 75. Burning Rock Biotech Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 76. Burning Rock Biotech Recent Development
Table 77. GENECAST Company Details
Table 78. GENECAST Business Overview
Table 79. GENECAST Early Detection of Multiple Cancers Product
Table 80. GENECAST Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 81. GENECAST Recent Development
Table 82. Labporatory for Advanced Medicine and Health Group Company Details
Table 83. Labporatory for Advanced Medicine and Health Group Business Overview
Table 84. Labporatory for Advanced Medicine and Health Group Early Detection of Multiple Cancers Product
Table 85. Labporatory for Advanced Medicine and Health Group Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 86. Labporatory for Advanced Medicine and Health Group Recent Development
Table 87. Singlera Genomics Company Details
Table 88. Singlera Genomics Business Overview
Table 89. Singlera Genomics Early Detection of Multiple Cancers Product
Table 90. Singlera Genomics Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 91. Singlera Genomics Recent Development
Table 92. Johns Hopkins Medicine Company Details
Table 93. Johns Hopkins Medicine Business Overview
Table 94. Johns Hopkins Medicine Early Detection of Multiple Cancers Product
Table 95. Johns Hopkins Medicine Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 96. Johns Hopkins Medicine Recent Development
Table 97. Bioscience Company Details
Table 98. Bioscience Business Overview
Table 99. Bioscience Early Detection of Multiple Cancers Product
Table 100. Bioscience Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 101. Bioscience Recent Development
Table 102. Genetron Holdings Company Details
Table 103. Genetron Holdings Business Overview
Table 104. Genetron Holdings Early Detection of Multiple Cancers Product
Table 105. Genetron Holdings Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 106. Genetron Holdings Recent Development
Table 107. Shenzhen Ruisi Company Details
Table 108. Shenzhen Ruisi Business Overview
Table 109. Shenzhen Ruisi Early Detection of Multiple Cancers Product
Table 110. Shenzhen Ruisi Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 111. Shenzhen Ruisi Recent Development
Table 112. Shanghai Majorbio Bio-Pharm Technology Company Details
Table 113. Shanghai Majorbio Bio-Pharm Technology Business Overview
Table 114. Shanghai Majorbio Bio-Pharm Technology Early Detection of Multiple Cancers Product
Table 115. Shanghai Majorbio Bio-Pharm Technology Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 116. Shanghai Majorbio Bio-Pharm Technology Recent Development
Table 117. Shanghai Gurong Company Details
Table 118. Shanghai Gurong Business Overview
Table 119. Shanghai Gurong Early Detection of Multiple Cancers Product
Table 120. Shanghai Gurong Revenue in Early Detection of Multiple Cancers Business (2020-2025) & (US$ Million)
Table 121. Shanghai Gurong Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Early Detection of Multiple Cancers Picture
Figure 2. Global Early Detection of Multiple Cancers Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Early Detection of Multiple Cancers Market Share by Type: 2024 VS 2031
Figure 4. Liquid Biopsy Features
Figure 5. Gene Panel Features
Figure 6. Others Features
Figure 7. Global Early Detection of Multiple Cancers Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Early Detection of Multiple Cancers Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Diagnostic Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Early Detection of Multiple Cancers Report Years Considered
Figure 13. Global Early Detection of Multiple Cancers Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Early Detection of Multiple Cancers Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Early Detection of Multiple Cancers Market Share by Region: 2024 VS 2031
Figure 16. Global Early Detection of Multiple Cancers Market Share by Players in 2024
Figure 17. Global Top Early Detection of Multiple Cancers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Early Detection of Multiple Cancers as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Early Detection of Multiple Cancers Revenue in 2024
Figure 19. North America Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Early Detection of Multiple Cancers Market Share by Country (2020-2031)
Figure 21. United States Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Early Detection of Multiple Cancers Market Share by Country (2020-2031)
Figure 25. Germany Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Early Detection of Multiple Cancers Market Share by Region (2020-2031)
Figure 33. China Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Early Detection of Multiple Cancers Market Share by Country (2020-2031)
Figure 41. Mexico Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Early Detection of Multiple Cancers Market Share by Country (2020-2031)
Figure 45. Turkey Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Early Detection of Multiple Cancers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Grail Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 49. Exact Sciences Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 50. Foundation Medicine Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 51. AnchorDx Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 52. Guardant Health Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 53. Burning Rock Biotech Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 54. GENECAST Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 55. Labporatory for Advanced Medicine and Health Group Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 56. Singlera Genomics Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 57. Johns Hopkins Medicine Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 58. Bioscience Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 59. Genetron Holdings Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 60. Shenzhen Ruisi Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 61. Shanghai Majorbio Bio-Pharm Technology Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 62. Shanghai Gurong Revenue Growth Rate in Early Detection of Multiple Cancers Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232